A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Exome (ES) or genome (GS) sequencing are recommended as first- or second-tier molecular tests for patients with developmental disorders (DD), but the clinical utility of GS continues to be debated. METHODS: This prospective randomized trial involving all Belgian human genetics centers compared the standard of care (SoC) - combining ES and chromosomal microarray analysis or shallow GS - with GS for 567 individuals with unexplained DD. The study was retrospectively registered. RESULTS: The diagnostic yield of GS was 39.8% (113/284) vs. 30% for SoC (85/283) (p = 0.015), mainly due to an increased detection of single nucleotide variants and indels (+ 8.7%). GS also enabled the detection of three non-coding (potential) pathogenic variants. Across both study arms, the diagnostic yield was higher for females (45.5%, 97/213) compared to males (28.5%, 101/354) (p < 0.001). Upon correction for the sex distribution and analytical differences between the study arms, the diagnostic yield difference between GS and SoC was reduced to 7.3% (p = 0.069). De novo variants were found for 23.6% of patients. Analysis of inherited variants in genes associated with autosomal dominant phenotypes contributed more to the diagnostic yield (3.9%) than X-linked variants (1.9%), and to a similar extent as autosomal recessive variants (4.1%). CONCLUSIONS: This nationwide study indicates GS outperforms SoC for the diagnosis of patients with DD in a decentralized hospital setting and well-characterized cohort. The results also highlight the importance of evaluating autosomal dominant inherited variants in genomics analyses for DD. TRIAL REGISTRATION: ClinicalTrials.gov (NCT07051213, 03-07-2025).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 1×
“Variants were classified according to the American College of Medical Genetics and Genomics/Association for Molecular Pathology and/or Association for Clinical Genomic Science classification guidelines [34, 35].”
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., Church, D. M., Crolla, J. A., Eichler, E. E., Epstein, C. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.006 · Cited by 2,882 · cited 1×
“%) indeed consisted of probands with prior negative CMA/sGS-based CNV analysis, and pathogenic CNVs are identified in approximately 12% of patients undergoing first-tier CMA/sGS for ID/CA [48, 49].”
Self-citationMosdepth: quick coverage calculation for genomes and exomes
Pedersen, B. S., & Quinlan, A. R. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx699 · Cited by 1,156
A structural variation reference for medical and population genetics
Collins, R. L., Brand, H., Karczewski, K. J., Zhao, X., Alföldi, J., Francioli, L. C., Khera, A. V., Lowther, C., Gauthier, L. D., Wang, H., et al. (2020) · Nature · doi:10.1038/s41586-020-2287-8 · Cited by 1,037
Genetic studies in intellectual disability and related disorders
Vissers, L. E. L. M., Gilissen, C., & Veltman, J. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg3999 · Cited by 761
Wright, C. F., Fitzgerald, T. W., Jones, W. D., Clayton, S., McRae, J. F., van Kogelenberg, M., King, D. A., Ambridge, K., Barrett, D. M., Bayzetinova, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61705-0 · Cited by 743
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report
The 100, 0. G. P. P. I. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035790 · Cited by 716
FMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711 · cited 1×
“GS also enabled diagnosis of one proband with Fragile-X syndrome, one of the most prevalent causes of ID in males [43], which is caused by a tandem repeat expansion in the FMR1 (MIM: 309550) promotor region.”
Haplotype-resolved diverse human genomes and integrated analysis of structural variation
Ebert, P., Audano, P. A., Zhu, Q., Rodriguez-Martin, B., Porubsky, D., Bonder, M. J., Sulovari, A., Ebler, J., Zhou, W., Serra Mari, R., et al. (2021) · Science · doi:10.1126/science.abf7117 · Cited by 702
Research works printed but not linked: 3
- Immacolata Spagnuolo M, López-Bueno R, Kosremelli Asmar M, et al. Global prevalence of developmental disabilities in children and adolescents: a systematic umbrella review. Front Public Health. Published online 2023. https://vizhub.healthdata.org/gbd-results/.
- Gross AM, Ajay SS, Rajan V, et al. Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease. Published online. 2018. https://doi.org/10.1038/s41436. · doi:10.1038/s41436
- Nurk S, Koren S, Rhie A, et al. The complete sequence of a human genome. Sci (1979). 2022;376:44–53. https://www.science.org.
Cited by
Closing the diagnostic gap in developmental disorders through comprehensive long-read sequencingPreprint
Bogaert, K. V. D., Geysens, M., Huremagic, B., Souche, E. L., Peeters, G., Olszewska, N., Meynants, S., Mancuso, G., Breckpot, J., Denayer, E., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9108777/v1 · Cited by 1
Self-citation
Metadata
- Authors
- Geysens, M., Souche, E., Baroni, M. C., Benoit, V., Beyltjens, T., Bossuyt, W., Bours, V., Crabbé, M., Croes, D., De Smet, M., Désir, J., Devriendt, K., Dheedene, A., Dimitrov, B. I., Janssens, K., Kumps, C., Lumaka, A., Menten, B., Meuwissen, M., Monestier, O., Mortier, G., Olsen, C., Palmeira, L., Peeters, H., Pölsler, L., Revencu, N., Roland, D., Soblet, J., Sznajer, Y., Taziaux, S., Van Esch, H., Vandeweyer, G., Vantroys, E., Vilain, C., Wiame, E., Van Den Bogaert, K., & Vermeesch, J. R.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- University of Antwerp (BE)
- Centre Hospitalier Universitaire de Liège (BE)
- Cliniques Universitaires Saint-Luc (BE)
- Institute of Pathology and Genetics (BE)
- Ghent University Hospital (BE)
- Vrije Universiteit Brussel (BE)
- Université Libre de Bruxelles (BE)
- Corresponding author
- Vermeesch, Joris Robert
- ORCID
- Souche, Erika
- Baroni, Maria Chiara
- Bossuyt, Wouter
- Bours, Vincent
- Désir, Julie
- Devriendt, Koenraad
- Dheedene, Annelies
- Dimitrov, Boyan Ivanov
- Janssens, Katrien
- Kumps, Candy
- Menten, Björn
- Meuwissen, Marije
- Monestier, Olivier
- Mortier, Geert
- Olsen, Catharina
- Peeters, Hilde
- Pölsler, Laura
- Roland, Dominique
- Soblet, Julie
- Sznajer, Yves
- Vandeweyer, Geert
- Vantroys, Elise
- Vermeesch, Joris Robert
- Venue
- Genome Medicine
- Published
- 2026-10-05
- Volume
- 18
- Issue
- 1
- ISSN
- 1756-994X (ISSN-L)
- PMC
- PMC13637178
- OpenAlex
- W7219642533
- Cited by
- 0
- References
- 57
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Genome Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- KU Leuven (C1-C14/22/125)
- Fonds Wetenschappelijk Onderzoek (T-003819N)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- developmental disorders, genome sequencing, diagnostic yield, standard of care comparison, genetic diagnosis
- MeSH terms
- Whole Genome Sequencing, Exome Sequencing, Child, Developmental Disabilities, Child, Preschool, Female, Genetic Testing, Humans, Male, Prospective Studies, Genome, Human, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care. https://app.cochat.ai/papers/10.1186/s13073-026-01771-2
- The paper
- Geysens, M., Souche, E., Baroni, M. C., Benoit, V., Beyltjens, T., Bossuyt, W., Bours, V., Crabbé, M., Croes, D., De Smet, M., Désir, J., Devriendt, K., Dheedene, A., Dimitrov, B. I., Janssens, K., Kumps, C., Lumaka, A., Menten, B., Meuwissen, M., . . . Vermeesch, J. R. (2026). A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care. Genome Medicine. https://doi.org/10.1186/s13073-026-01771-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.